» Articles » PMID: 10861440

Expression of Hypoxia-inducible Factor 1alpha in Brain Tumors: Association with Angiogenesis, Invasion, and Progression

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2000 Jun 22
PMID 10861440
Citations 201
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypoxia inducible factor-1 (HIF-1) plays a critical role in angiogenesis during vascular development. The authors tested the hypothesis that HIF-1 expression correlates with progression and angiogenesis in brain tumors.

Methods: The authors investigated the expression of the HIF-1alpha and HIF-1beta subunits in human glioma cell lines and brain tumor tissues using Western blot analysis and immunohistochemistry.

Results: In glioblastomas multiforme (GBMs), HIF-1alpha primarily was localized in pseudopalisading cells around areas of necrosis and in tumor cells infiltrating the brain at the tumor margin. In contrast, HIF-1alpha was expressed in stromal cells throughout hemangioblastomas (HBs). Like HIF-1alpha, HIF-1beta was most highly expressed in high grade tumors but was expressed more widely than HIF-1alpha, including cells away from necrotic zones. In the brains of mice injected with Glioma 261 cells, a pattern of HIF-1alpha expression identical to that observed in human GBMs was noted.

Conclusions: In GBMs, the heterogeneous pattern of HIF-1alpha expression appears to be determined at least in part by tissue oxygenation, whereas in HBs the homogeneous expression of HIF-1alpha may be driven by an oncogenic rather than a physiologic stimulus.

Citing Articles

Metabolic adaptation of myeloid cells in the glioblastoma microenvironment.

Essakhi N, Bertucci A, Baeza-Kallee N, Colin C, Lavignolle-Heguy R, Garcia-Gonzalez P Front Immunol. 2025; 15:1431112.

PMID: 39763643 PMC: 11700814. DOI: 10.3389/fimmu.2024.1431112.


Impact of hypoxia on the molecular content of glioblastoma-derived exosomes.

Di Giulio S, Carata E, Muci M, Mariano S, Panzarini E Extracell Vesicles Circ Nucl Acids. 2024; 5(1):1-15.

PMID: 39698411 PMC: 11648508. DOI: 10.20517/evcna.2023.52.


Serum HIF-1α, IGF-1 and IGFBP-3 correlate to recurrence and overall survival in early-stage hepatocellular carcinoma patients.

Ding S, Ding W, Zhang Y, Chen Y, Tang H, Jiang X Biomark Med. 2024; 18(23):1027-1036.

PMID: 39552593 PMC: 11633424. DOI: 10.1080/17520363.2024.2421149.


Gating residues govern ligand unbinding kinetics from the buried cavity in HIF-2α PAS-B.

Silvestrini M, Solazzo R, Boral S, Cocco M, Closson J, Masetti M Protein Sci. 2024; 33(11):e5198.

PMID: 39467204 PMC: 11516114. DOI: 10.1002/pro.5198.


Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer.

Hoffmann H, Wartenberg M, Vorlova S, Karl-Scholler F, Kallius M, Reinhardt O Oncogene. 2024; 43(35):2661-2676.

PMID: 39095583 PMC: 11347376. DOI: 10.1038/s41388-024-03113-1.